AÇÃO DO LÚPULO EM PACIENTES QUE FAZEM USO DE MEDICAMENTOS PSICOTRÓPICOS

Authors

  • Klemeson Nunes Alfa Unipac Polo Teófilo Otoni
  • Aline Ribeiro de Souza Faculdade Presidente Antônio Carlos de Teófilo Otoni
  • Larissa Pereira Batista Universidade Federal dos Vales do Jequitinhonha e Mucuri
  • Pedro Emílio Amador Salomão Faculdade Presidente Antônio Carlos de Teófilo Otoni

DOI:

https://doi.org/10.61164/rmnm.v6i1.2588

Keywords:

Hops; interaction; Medicinal Properties; Treatment

Abstract

This study explores the interaction of hops (Humulus lupulus) with psychotropic medications, highlighting their potential therapeutic benefits and associated risks. Hops, known for their sedative and anxiolytic properties due to compounds such as alpha acids and 8-prenylnaringenin, can be used to treat anxiety and insomnia disorders. However, when combined with psychotropic medications like antidepressants and anxiolytics, there is a potential to potentiate sedative effects, increasing the risk of excessive sedation and cognitive impairment. Additionally, hops can influence the pharmacokinetics of medications by altering their absorption and metabolism through the cytochrome P450 system. This study underscores the need for rigorous clinical monitoring when considering the combination of hops and psychotropic medications, aiming to maximize therapeutic benefits while minimizing risks to patient health.

Downloads

Download data is not yet available.

Author Biography

  • Aline Ribeiro de Souza, Faculdade Presidente Antônio Carlos de Teófilo Otoni

     

     

References

Stahl, S. M. (2013). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press.

• G1. (1 de abril de 2024). Da cerveja à medicina: Entenda como lúpulo pode ser usado contra os vírus chikungunya e oropouche. Recuperado de G1.

• Bhattacharyya, S., Sharma, V. K., & Sharma, A. (2011). Medicinal Properties of Humulus Lupulus L. (Hops): A Review. Indian Journal of Natural Products and Resources, 2(3), 292-299.

• Jones, M. (2020). Herbal Interactions with Psychotropic Medications: A Review. Journal of Clinical Pharmacology, 60(5), 570-580. DOI:10.1002/jcph.1598.

• Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry. 2004;65(10):1317-1330.

• Miranda CL, Stevens JF, Helmrich A, et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol. 1999;37(4):271-285. PubMed

• Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008;116(3):383-396.

• Gerhäuser C. Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol Nutr Food Res. 2005;49(9):827-831.

• Chadwick LR, Pauli GF, Farnsworth NR. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine. 2006;13(1-2):119-131.

• Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010;17(6):389-396.

Downloads

Published

2024-06-28

Issue

Vol. 6 No. 1 (2024): Revista Multidisciplinar do Nordeste Mineiro

Section

Artigos

License

Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish in this journal agree to the following terms:

Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;

Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;

Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);

Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.

PRIVACY POLICY

The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.

Note: All content of the work is the sole responsibility of the author and the advisor.

How to Cite

AÇÃO DO LÚPULO EM PACIENTES QUE FAZEM USO DE MEDICAMENTOS PSICOTRÓPICOS. (2024). REMUNOM, 6(1). https://doi.org/10.61164/rmnm.v6i1.2588